poisar

Stock

Stevanato Group S.p.A. STVN

$22.13-1.27%

Overview

STVN market data

Price History

STVN price chart · 1M
O
22.35
H
22.38
L
22.13
C
22.13
Vol
20,592.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$22.35
Previous Close
$22.42
Day High
$22.38
Day Low
$22.13
52 Week High
$23.17
52 Week Low
$16.05
7 Day Return
-0.87%
30 Day Return
+9.50%
90 Day Return
+19.30%
1 Year Return
+36.44%
Daily Notional Volume
$455.7K
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
37.83
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
$0.51
Diluted earnings per share over the trailing twelve months.
Beta
0.76
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
0.2%
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
11.0%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$12.89 – $28.00
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $5.9B · P/B 3.20 · P/S 4.16.

Company News

8 captured
Stevanato Group Q2 2026 Earnings Call: Complete TranscriptBenzinga · Aug 4, 2026, 1:36 PM
Stevanato Group Lowers FY2026 GAAP EPS Guidance from $0.64-$0.69 to $0.62-$0.64; Lowers FY2026 Sales Guidance from $1.467B-$1.500B to $1.465B-$1.488BBenzinga · Aug 4, 2026, 10:43 AM
Stevanato Group Narrows FY2026 Adj EPS Guidance from $0.69-$0.73 to $0.70-$0.72 vs $0.68 Est; Lowers FY2026 Sales Guidance from $1.467B-$1.500B to $1.465B-$1.488B vs $1.500B EstBenzinga · Aug 4, 2026, 10:40 AM
Stevanato Gr Q2 Adj. EPS $0.16 Beats $0.14 Estimate, Sales $351.091M Miss $351.370M EstimateBenzinga · Aug 4, 2026, 10:30 AM
Stevanato Group Says Liraglutide-Based Combination Products Incorporating Its Proprietary Alina Pen Injector Platform Receives Marketing Authorizations In EuropeBenzinga · Jul 30, 2026, 10:37 AM
TD Cowen Initiates Coverage On Stevanato Group with Buy Rating, Announces Price Target of $25Benzinga · Jun 16, 2026, 5:10 PM
Merlin, Concrete Pumping Holdings, And Krispy Kreme And Other Big Stocks Moving Higher On FridayBenzinga · Jun 5, 2026, 2:40 PM
Wolfe Research Assumes Stevanato Group at Outperform, Announces Price Target of $21Benzinga · Jun 2, 2026, 11:30 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock